Page last updated: 2024-08-26

lysophosphatidic acid and Angiogenesis, Pathologic

lysophosphatidic acid has been researched along with Angiogenesis, Pathologic in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (37.50)29.6817
2010's14 (58.33)24.3611
2020's1 (4.17)2.80

Authors

AuthorsStudies
Amaral, RFD; dosSantos, MF; Fonseca, ACCD; Freitas, C; Garcia, C; Geraldo, LHM; Lima, FRS; Mendes, FA; Spohr, TCLS1
Ando, K; Eino, D; Fukuhara, S; Iba, T; Ishii, S; Kidoya, H; Kishima, H; Mochizuki, N; Muramatsu, F; Naito, H; Takakura, N; Takara, K; Tsukada, Y; Wakabayashi, T; Yasuda, D1
Hisano, Y; Hla, T1
Buffa, J; DiDonato, JA; Finke, J; Fisher, EA; Hatala, D; Hazen, SL; Klipfell, E; Lindner, D; Parker, Y; Parsons-Wingerter, P; Rayman, P; Smith, JD; Tallant, TC; Wang, Z; Yusufishaq, MSS; Zamanian-Daryoush, M1
Chen, Y; Ramakrishnan, DP; Ren, B1
Huang, YL; Lan, SY; Lee, H; Lin, YC; Wu, PY1
Araki, M; Dong, Y; Fukushima, N; Hirane, M; Kitayoshi, M; Tanabe, E; Tsujiuchi, T1
Burgess, A; Drummond, K; Kaye, AH; Morokoff, A; Ng, W; Pébay, A1
Leblanc, R; Peyruchaud, O1
Cai, XY; Chen, J; Fan, JQ; Li, ZY; Ren, JH; Wu, G; Xia, Y; Zhang, LL; Zhang, RG; Zhu, F1
Best, B; Ramakrishnan, DP; Ren, B; Silverstein, RL; Storz, P; Walcott, BP1
Brindley, DN; Curtis, JM; Tang, X; Wang, X; Zhao, YY1
Fang, X; Lee, Z; Mukherjee, A; Oyesanya, RA; Song, Y; Wu, J1
Fishman, DA; Wang, F1
Bekele, R; Brindley, DN; Capatos, D; Samadi, N; Sariahmetoglu, M; Venkatraman, G1
Anantharamaiah, GM; Chattopadhyay, A; Farias-Eisner, R; Fogelman, AM; Ganapathy, E; Gao, F; Grijalva, V; Imaizumi, S; Johnston, B; Meriwether, D; Navab, M; Reddy, ST; Roberts, S; Shah, N; Su, F; Vasquez, SX1
Chattopadhyay, A; Farias-Eisner, R; Fogelman, AM; Gao, F; Grijalva, V; Navab, M; Reddy, ST; Su, F1
Fukushima, N; Ishibashi, T; Kondo, M; Nishihira, J; Sato, Y; Sun, B; Suzuki, M; Todo, S1
Aitsebaomo, J; Der, CJ; Kedar, V; Kingsley-Kallesen, ML; Moser, M; Patterson, C; Wennerberg, K; Zeng, GQ; Zhang, C1
Gupta, GP; Massagué, J1
Christodoulou, E; Goding, JW; Kikuchi, K; Moolenaar, WH; Nagano, T; Perrakis, A; Ruurs, P; Takakusa, H; van Meeteren, LA1
Aoki, J; Arai, H; Iseki, S; Kishi, Y; Noji, S; Ohkawa, R; Okudaira, S; Ota, M; Tanaka, M; Yatomi, Y1
Bae, GU; Chung, HC; Han, JW; Kim, BK; Kim, YK; Lee, EK; Lee, HY; Lee, J; Park, CG; Park, SY; Rha, SY1
Brinkmann, V; Lynch, KR; Moolenaar, WH; Saulnier-Blache, JS; van Meeteren, LA1

Reviews

8 review(s) available for lysophosphatidic acid and Angiogenesis, Pathologic

ArticleYear
Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies.
    Signal transduction and targeted therapy, 2021, 02-01, Volume: 6, Issue:1

    Topics: Humans; Lysophospholipids; Molecular Targeted Therapy; Neovascularization, Pathologic; Phospholipids; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid; Signal Transduction

2021
Bioactive lysolipids in cancer and angiogenesis.
    Pharmacology & therapeutics, 2019, Volume: 193

    Topics: Animals; Cell Movement; Humans; Lysophospholipids; Neoplasms; Neovascularization, Pathologic; Sphingosine

2019
Regulation of angiogenesis by phospholipid lysophosphatidic acid.
    Frontiers in bioscience (Landmark edition), 2013, 06-01, Volume: 18, Issue:3

    Topics: Endothelium, Vascular; Gene Expression Regulation; Humans; Lysophospholipids; Neovascularization, Pathologic; Neovascularization, Physiologic

2013
Complexities of lysophospholipid signalling in glioblastoma.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2014, Volume: 21, Issue:6

    Topics: Animals; Brain Neoplasms; Cell Movement; Glioblastoma; Humans; Lysophospholipids; Neovascularization, Pathologic; Signal Transduction

2014
New insights into the autotaxin/LPA axis in cancer development and metastasis.
    Experimental cell research, 2015, May-01, Volume: 333, Issue:2

    Topics: Animals; Bone Neoplasms; Carcinogenesis; Humans; Lysophospholipids; Neovascularization, Pathologic; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid; Signal Transduction

2015
Lysophosphatidic acid and invasion.
    Cancer treatment and research, 2009, Volume: 149

    Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cyclooxygenase 2; Diterpenes; Female; Humans; Interleukins; Intracellular Signaling Peptides and Proteins; Lysophospholipids; Membrane Lipids; Mice; Multienzyme Complexes; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neovascularization, Pathologic; Ovarian Neoplasms; Peptide Hydrolases; Phosphodiesterase I; Phospholipases A; Phosphoric Diester Hydrolases; Pyrophosphatases; Receptors, Lysophosphatidic Acid; Signal Transduction; Sphingosine; Vascular Endothelial Growth Factor A

2009
Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
    Biochimie, 2011, Volume: 93, Issue:1

    Topics: Animals; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Intercellular Signaling Peptides and Proteins; Lysophospholipids; Male; Mice; Multienzyme Complexes; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Phosphatidate Phosphatase; Phosphodiesterase I; Phospholipase D; Phosphoric Diester Hydrolases; Pyrophosphatases; Signal Transduction; Sphingosine

2011
Platelets and metastasis revisited: a novel fatty link.
    The Journal of clinical investigation, 2004, Volume: 114, Issue:12

    Topics: Blood Platelets; Bone and Bones; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Humans; Lysophospholipids; Models, Biological; Neoplasm Metastasis; Neovascularization, Pathologic; Osteolysis; Ovarian Neoplasms

2004

Other Studies

16 other study(ies) available for lysophosphatidic acid and Angiogenesis, Pathologic

ArticleYear
Lysophosphatidic Acid Receptor 4 Activation Augments Drug Delivery in Tumors by Tightening Endothelial Cell-Cell Contact.
    Cell reports, 2017, Aug-29, Volume: 20, Issue:9

    Topics: Animals; Antigens, CD; Cadherins; Cell Communication; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Drug Delivery Systems; Endothelial Cells; Lysophospholipids; Mice; Neoplasms; Neovascularization, Pathologic; Receptors, Lysophosphatidic Acid; Signal Transduction

2017
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects.
    The Journal of biological chemistry, 2013, Jul-19, Volume: 288, Issue:29

    Topics: Animals; Antigen Presentation; Antineoplastic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Carcinogenesis; Cardiotonic Agents; Cell Line, Tumor; Cell Proliferation; Dendritic Cells; Female; Humans; Immunity; Immunocompetence; Lipoproteins, HDL; Lysophospholipids; Macrophages; Male; Matrix Metalloproteinase 9; Mice; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Remission Induction; Survival Analysis; Tumor Microenvironment

2013
Aromatic hydrocarbon receptor inhibits lysophosphatidic acid-induced vascular endothelial growth factor-A expression in PC-3 prostate cancer cells.
    Biochemical and biophysical research communications, 2013, Aug-02, Volume: 437, Issue:3

    Topics: Angiogenesis Inducing Agents; Aryl Hydrocarbon Receptor Nuclear Translocator; Cell Line, Tumor; HEK293 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lysophospholipids; Male; Neoplasm Metastasis; Neovascularization, Pathologic; Prostatic Neoplasms; Receptors, Aryl Hydrocarbon; Signal Transduction; Vascular Endothelial Growth Factor A

2013
Downregulation of activation factors of endothelia and fibroblasts via lysophosphatidic acid signaling in a mouse lung cancer LL/2 cell line.
    Journal of receptor and signal transduction research, 2013, Volume: 33, Issue:5

    Topics: 3T3 Cells; Animals; Cell Movement; Endothelial Cells; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Lysophospholipids; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms, Experimental; Neovascularization, Pathologic; Receptors, Lysophosphatidic Acid; Signal Transduction; Vascular Endothelial Growth Factor A

2013
Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:7

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lysophospholipids; Male; Melanoma, Experimental; Mice, Inbred C57BL; Microscopy, Confocal; Neoplasm Transplantation; Neovascularization, Pathologic; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; Tumor Burden

2015
LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.
    Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:6

    Topics: Animals; Carcinoma, Lewis Lung; CD36 Antigens; Cell Nucleus; Cells, Cultured; Cellular Reprogramming; Down-Regulation; Endothelial Cells; Ephrin-B2; Forkhead Box Protein O1; Histone Deacetylases; Humans; Lysophospholipids; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; Protein Kinase C; RNA Interference; Transcription, Genetic; Transfection

2016
Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.
    Molecular cancer, 2017, 02-08, Volume: 16, Issue:1

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cytokines; Disease Models, Animal; Doxycycline; Female; Humans; Inflammation; Inflammation Mediators; Lysophospholipids; Macrophages; Mice; Neovascularization, Pathologic; NF-kappa B; Phosphorylation; Protein Transport; Tumor Burden; Xenograft Model Antitumor Assays

2017
Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jan-15, Volume: 15, Issue:2

    Topics: Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lysophospholipids; Models, Biological; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphorylation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Sp1 Transcription Factor; Vascular Endothelial Growth Factor A

2009
L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
    Integrative biology : quantitative biosciences from nano to macro, 2011, Volume: 3, Issue:4

    Topics: Amino Acid Sequence; Angiogenesis Inhibitors; Animals; Apolipoprotein A-I; Blood Vessels; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Female; Fibroblast Growth Factor 2; Gene Expression; Humans; Intercellular Signaling Peptides and Proteins; Lysophospholipids; Mice; Mice, Inbred C57BL; Models, Biological; Molecular Mimicry; Molecular Sequence Data; Neovascularization, Pathologic; Neovascularization, Physiologic; Ovarian Neoplasms; Peptide Fragments; Peptides; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2011
Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1α in human ovarian cancer cell lines and a mouse ovarian cancer model.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:2

    Topics: Animals; Apolipoprotein A-I; Cell Line, Tumor; Cobalt; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin; Intercellular Signaling Peptides and Proteins; Lysophospholipids; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Ovarian Neoplasms; Oxygen; Peptides; Peptidomimetics; Phosphorylation; Proteasome Endopeptidase Complex; Proteolysis; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Ribosomal Protein S6 Kinases, 70-kDa; Transcription, Genetic

2012
Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis.
    International journal of molecular medicine, 2003, Volume: 12, Issue:4

    Topics: Animals; Cell Division; Cell Line, Tumor; Cyclin D1; DNA; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Immunoblotting; Lysophospholipids; Macrophage Migration-Inhibitory Factors; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Phosphorylation; ras Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Double-Stranded; RNA, Messenger; Signal Transduction; Time Factors; Transfection; Tyrosine; Up-Regulation; Vascular Endothelial Growth Factor A

2003
p68RacGAP is a novel GTPase-activating protein that interacts with vascular endothelial zinc finger-1 and modulates endothelial cell capillary formation.
    The Journal of biological chemistry, 2004, Apr-23, Volume: 279, Issue:17

    Topics: Amino Acid Sequence; Animals; Base Sequence; Blotting, Northern; Bradykinin; Capillaries; Cell Line; COS Cells; DNA-Binding Proteins; Endothelial Cells; Endothelin-1; Endothelium, Vascular; Green Fluorescent Proteins; GTPase-Activating Proteins; Immunohistochemistry; Kruppel-Like Transcription Factors; Luciferases; Luminescent Proteins; Lysophospholipids; Mice; Models, Genetic; Molecular Sequence Data; Mutagenesis, Site-Directed; Neovascularization, Pathologic; NIH 3T3 Cells; Phylogeny; Plasmids; Platelet-Derived Growth Factor; Precipitin Tests; Promoter Regions, Genetic; Protein Binding; Protein Structure, Tertiary; RNA; RNA, Messenger; Signal Transduction; Tissue Distribution; Transcription Factors; Transcription, Genetic; Transfection; Two-Hybrid System Techniques

2004
Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.
    The Journal of biological chemistry, 2005, Jun-03, Volume: 280, Issue:22

    Topics: Allosteric Site; Binding Sites; Biosensing Techniques; Blotting, Western; Catalysis; Catalytic Domain; Cell Line; Cell Movement; DNA, Complementary; Dose-Response Relationship, Drug; Fluorescence Resonance Energy Transfer; Glucose-6-Phosphate Isomerase; Glycoproteins; Humans; Hydrolysis; Kinetics; Ligands; Lipid Metabolism; Lipids; Lysophosphatidylcholines; Lysophospholipids; Models, Chemical; Multienzyme Complexes; Mutagenesis; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Phosphodiesterase I; Phospholipase D; Phosphoric Diester Hydrolases; Pyrophosphatases; Recombinant Fusion Proteins; Recombinant Proteins; Sphingosine; Transfection

2005
Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid.
    The Journal of biological chemistry, 2006, Sep-01, Volume: 281, Issue:35

    Topics: Animals; Gene Expression Regulation, Developmental; Genetic Techniques; Heterozygote; Lysophospholipids; Mice; Mice, Knockout; Models, Genetic; Multienzyme Complexes; Neovascularization, Pathologic; Phenotype; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pyrophosphatases; Recombinant Proteins; Signal Transduction; Time Factors

2006
Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Nov-01, Volume: 12, Issue:21

    Topics: Blotting, Western; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoprecipitation; Lysophospholipids; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Transfection; Vascular Endothelial Growth Factor A

2006
Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.
    Cancer letters, 2008, Aug-08, Volume: 266, Issue:2

    Topics: Animals; Antineoplastic Agents; Female; Humans; Lysophospholipids; Mice; Mice, Inbred C57BL; Multienzyme Complexes; Neoplasm Metastasis; Neovascularization, Pathologic; Organophosphates; Phosphodiesterase I; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrophosphatases; Sphingosine

2008